Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
Clinical Medicine (London, England)
|
March 9, 2006
Autoimmune hepatitis
Stefan Lueth, Ansgar W Lohse
Liver International : Official Journal of the International Association for the Study of the Liver
|
July 2, 2026
Emerging Immune-Based Therapeutic Strategies in Hepatocellular Carcinoma
Janine Kah, Werner Dammermann, Stefan Lueth
Hepatology (Baltimore, Md.)
|
April 30, 2003
MHC class II-expressing hepatocytes function as antigen-presenting cells and activate specific CD4 T lymphocyutes
Johannes Herkel, Bettina Jagemann, Christiane Wiegard, et al.
Annals of Hepatology
|
January 5, 2017
High clinical manifestation rate in an imported outbreak of hepatitis E genotype 1 infection in a German group of travellers returning from India
Sven Pischke, Julian Schulze-Zur-Wiesch, Marc Lütgehetmann, et al.
World Journal of Gastroenterology
|
August 26, 2014
Age-related differences in response to peginterferon alfa-2a/ribavirin in patients with chronic hepatitis C infection
Claudia Roeder, Sabine Jordan, Julian Schulze Zur Wiesch, et al.
Plos One
|
December 25, 2015
Performance and Value of IFN-Lambda3 and IFN-Lambda4 Genotyping in Patients with Chronic Hepatitis C (CHC) Genotype 2/3 in a Real World Setting
Steffen B Wiegand, Benjamin Heidrich, Simone Susser, et al.
Plos Neglected Tropical Diseases
|
March 3, 2026
The underestimated burden of placental schistosomiasis in endemic regions: Findings from a cross-sectional, diagnostic proof-of-concept study on placental schistosomiasis in Gabon
Saskia Dede Davi, Dearie Glory Okwu, Yabo Josiane Honkpehedji, et al.
World Journal of Gastroenterology
|
March 30, 2016
Daclatasvir vs telaprevir plus peginterferon alfa/ribavirin for hepatitis C virus genotype 1
Ira Jacobson, Stefan Zeuzem, Robert Flisiak, et al.
Frontiers in Immunology
|
June 15, 2017
Peg-Interferon Lambda Treatment Induces Robust Innate and Adaptive Immunity in Chronic Hepatitis B Patients
Sandra Phillips, Sameer Mistry, Antonio Riva, et al.
Journal of Hepatology
|
July 28, 2014
A randomized phase 2b study of peginterferon lambda-1a for the treatment of chronic HCV infection
Andrew J Muir, Sanjeev Arora, Gregory Everson, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
Clinical Medicine (London, England)
|
March 9, 2006
Autoimmune hepatitis
Stefan Lueth, Ansgar W Lohse
Liver International : Official Journal of the International Association for the Study of the Liver
|
July 2, 2026
Emerging Immune-Based Therapeutic Strategies in Hepatocellular Carcinoma
Janine Kah, Werner Dammermann, Stefan Lueth
Hepatology (Baltimore, Md.)
|
April 30, 2003
MHC class II-expressing hepatocytes function as antigen-presenting cells and activate specific CD4 T lymphocyutes
Johannes Herkel, Bettina Jagemann, Christiane Wiegard, et al.
Annals of Hepatology
|
January 5, 2017
High clinical manifestation rate in an imported outbreak of hepatitis E genotype 1 infection in a German group of travellers returning from India
Sven Pischke, Julian Schulze-Zur-Wiesch, Marc Lütgehetmann, et al.
World Journal of Gastroenterology
|
August 26, 2014
Age-related differences in response to peginterferon alfa-2a/ribavirin in patients with chronic hepatitis C infection
Claudia Roeder, Sabine Jordan, Julian Schulze Zur Wiesch, et al.
Plos One
|
December 25, 2015
Performance and Value of IFN-Lambda3 and IFN-Lambda4 Genotyping in Patients with Chronic Hepatitis C (CHC) Genotype 2/3 in a Real World Setting
Steffen B Wiegand, Benjamin Heidrich, Simone Susser, et al.
Plos Neglected Tropical Diseases
|
March 3, 2026
The underestimated burden of placental schistosomiasis in endemic regions: Findings from a cross-sectional, diagnostic proof-of-concept study on placental schistosomiasis in Gabon
Saskia Dede Davi, Dearie Glory Okwu, Yabo Josiane Honkpehedji, et al.
World Journal of Gastroenterology
|
March 30, 2016
Daclatasvir vs telaprevir plus peginterferon alfa/ribavirin for hepatitis C virus genotype 1
Ira Jacobson, Stefan Zeuzem, Robert Flisiak, et al.
Frontiers in Immunology
|
June 15, 2017
Peg-Interferon Lambda Treatment Induces Robust Innate and Adaptive Immunity in Chronic Hepatitis B Patients
Sandra Phillips, Sameer Mistry, Antonio Riva, et al.
Journal of Hepatology
|
July 28, 2014
A randomized phase 2b study of peginterferon lambda-1a for the treatment of chronic HCV infection
Andrew J Muir, Sanjeev Arora, Gregory Everson, et al.
Page
of 1